Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary

Gynecologic Oncology

Volumn 108, Issue 2, 2008, Pages 370-376

  Guirguis, Alfred ^a   Elishaev, Esther ^a   Oh, Sung Hee ^b   Tseng, George C ^b   Zorn, Kristin ^a   DeLoia, Julie A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Endometrial cancer; Endometrioid carcinoma; Molecular profiling; Ovarian cancer; Synchronous

Indexed keywords

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER STAGING; DISEASE CLASSIFICATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OVARY; OVARY TUMOR; PREDICTION; PRIORITY JOURNAL; SCALE UP; STATISTICAL MODEL; TRAINING;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 38649123349     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.10.008     Document Type: Article

References (31)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 56 2 (2006) 106-130
2. Walsh C., Holschneider C., Hoang Y., Tieu K., Karlan B., and Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106 4 (2005) 693-699
3. Kline R.C., Wharton J.T., Atkinson E.N., Burke T.W., Gershenson D.M., and Edwards C.L. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol 39 3 (1990) 337-346
4. Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., and Buller R.E. Simultaneously detected endometrial and ovarian carcinomas-a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol 83 2 (2001) 355-362
5. Ulbright T.M., and Roth L.M. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 16 1 (1985) 28-34
6. Moreno-Bueno G., Gamallo C., Perez-Gallego L., de Mora J.C., Suarez A., and Palacios J. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 10 2 (2001) 116-122
7. Chang K.H., Albarracin C., Luthra R., et al. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis. Int J Gynecol Cancer 16 1 (2006) 178-182
8. Halperin R., Zehavi S., Hadas E., Habler L., Bukovsky I., and Schneider D. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination. Int J Gynecol Cancer 13 1 (2003) 32-37
9. Brinkmann D., Ryan A., Ayhan A., et al. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. J Natl Cancer Inst 96 19 (2004) 1441-1446
10. Fujita M., Enomoto T., Wada H., Inoue M., Okudaira Y., and Shroyer K.R. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol 105 3 (1996) 350-359
11. Catasus L., Bussaglia E., Rodrguez I., et al. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 35 11 (2004) 1360-1368
12. Irving J.A., Catasus L., Gallardo A., et al. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Hum Pathol 36 6 (2005) 605-619
13. Mutter G.L., Lin M.C., Fitzgerald J.T., et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92 11 (2000) 924-930
14. Sato N., Tsunoda H., Nishida M., et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60 24 (2000) 7052-7056
15. Lax S.F. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444 3 (2004) 213-223
16. Obata K., Morland S.J., Watson R.H., et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58 10 (1998) 2095-2097
17. MacDonald N.D., Salvesen H.B., Ryan A., Iversen O.E., Akslen L.A., and Jacobs I.J. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res 60 6 (2000) 1750-1752
18. Hecht J.L., and Mutter G.L. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 24 29 (2006) 4783-4791
19. Esteller M., Levine R., Baylin S.B., Ellenson L.H., and Herman J.G. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17 18 (1998) 2413-2417
20. Gurin C.C., Federici M.G., Kang L., and Boyd J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 59 2 (1999) 462-466
21. Caduff R.F., Johnston C.M., and Frank T.S. Mutations of the Ki-ras oncogene in carcinoma of the endometrium. Am J Pathol 146 1 (1995) 182-188
22. Dinulescu D.M., Ince T.A., Quade B.J., Shafer S.A., Crowley D., and Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11 1 (2005) 63-70
23. Schlosshauer P.W., Pirog E.C., Levine R.L., and Ellenson L.H. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod Pathol 13 10 (2000) 1066-1071
24. Palacios J., and Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58 7 (1998) 1344-1347
25. Fehrmann R.S., Li X.Y., van der Zee A.G., et al. Profiling studies in ovarian cancer: a review. Oncologist 12 8 (2007) 960-966
26. Prowse A.H., Manek S., Varma R., et al. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer 119 3 (2006) 556-562
27. Troyanskaya O., Cantor M., Sherlock G., et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17 6 (2001) 520-525
28. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 9 (2001) 5116-5121
29. Robboy S.J., Duggan M., and Kurman R.J. The Female Reproductive System. 2nd edition (1988), LB Lippincott, Philadelphia
30. Vilgelm A., Lian Z., Wang H., et al. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Cancer Res 66 7 (2006) 3375-3380
31. Mukherjee S., Tamayo P., Rogers S., et al. Estimating dataset size requirements for classifying DNA microarray data. J Comput Biol 10 2 (2003) 119-142